[LS-32] Luncheon Seminar 32「MG treatment considered from the patient's benefit」

[LS-32-2] Complement role in the pathogenesis of MG -Clinical application of complement inhibitor, Ultomiris-

Akiyuki Uzawa (Department of Neurology, Graduate School of Medicine, Chiba University, Japan)